NCT05035914

Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: UNKNOWN

Phase: PHASE1, PHASE2

Sponsor: Guangzhou University of Traditional Chinese Medicine

Condition: Advanced Colorectal Cancer

Signal summary

Public flags

Status signal: Unknown Status Signal

Timeline signals: stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal

Results signal: Low Signal

Operational burden: rare_population_signal

Stopped reason

Context when available

No stop reason available in the current public record.